Biogen Inc. BIIB NASDAQ

Biogen Inc. (BIIB) reported total assets of $29.44B and total liabilities of $11.18B for quarter ending 2025-12-31, resulting in total equity of $18.26B.

The company held $3.82B in cash and short-term investments. Total debt stood at $6.95B, with net debt of $3.94B. The Debt-to-Equity (D/E) ratio was 0.38 (conservative).

Current ratio is 2.68, indicating strong short-term liquidity. Interest coverage is -0.8x (weak).

Criteria supported by this page:

• HEALTH (83/100, Pass) — Debt-to-Equity of 0.38, current ratio of 2.68, interest coverage -0.8x — balance sheet is strong
• MOAT (65/100) — Total assets $29.44B and equity $18.26B support the company's competitive scale
• VALUE (47/100) — Debt-to-Equity 0.38 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 60/100 with 2/7 criteria passed.